Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Accounts Payables (2021 - 2025)

Rxo (RXO) has disclosed Accounts Payables for 5 consecutive years, with $539.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables fell 5.11% year-over-year to $539.0 million, compared with a TTM value of $539.0 million through Dec 2025, down 5.11%, and an annual FY2025 reading of $539.0 million, down 5.11% over the prior year.
  • Accounts Payables was $539.0 million for Q4 2025 at Rxo, up from $481.0 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $572.0 million in Q3 2024 and bottomed at $372.0 million in Q1 2024.
  • Average Accounts Payables over 5 years is $482.1 million, with a median of $496.0 million recorded in 2023.
  • Peak annual rise in Accounts Payables hit 37.2% in 2024, while the deepest fall reached 25.0% in 2024.
  • Year by year, Accounts Payables stood at $520.0 million in 2021, then decreased by 3.65% to $501.0 million in 2022, then decreased by 17.37% to $414.0 million in 2023, then soared by 37.2% to $568.0 million in 2024, then decreased by 5.11% to $539.0 million in 2025.
  • Business Quant data shows Accounts Payables for RXO at $539.0 million in Q4 2025, $481.0 million in Q3 2025, and $461.0 million in Q2 2025.